KLAC(KLAC)
KLAC
Q4 2026 EPS Estimate
$1.17
Oct 28, 2026 · Reports after close
Revenue Estimate
$4.04B
FY2027E EPS$5.48
FY2028E EPS$6.66
Analyst Sentiment
Wall St. Consensus
Buy24 analysts·High coverage
68
Score
17 Buy (71%)7 Hold (29%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1771%
Hold
729%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$180.00
-3.2%
Consensus
$225.00
+21.1%
Bull
$325.00
+74.9%
12-Month Target Range24 analysts
$180.00$225.00$325.00
Current $185.86Consensus
Current Price
$185.86
Upside to Consensus
$39.14
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+33.87%
EPS+47.79%
FY2028
Rev+19.38%
EPS+21.47%
FY2029
Rev+12.13%
EPS+14.72%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $18.11B | $21.62B | $24.24B | $27.75B | $31.77B |
| Low | $17.35B | $20.32B | $22.46B | $25.19B | $28.84B |
| High | $18.70B | $23.01B | $26.29B | $29.82B | $34.14B |
| EBITDA Avg | $7.70B | $9.19B | $10.31B | $11.80B | $13.51B |
| Low | $7.38B | $8.64B | $9.55B | $10.71B | $12.26B |
| High | $7.95B | $9.78B | $11.18B | $12.68B | $14.51B |
| EBIT Avg | $7.12B | $8.50B | $9.53B | $10.91B | $12.49B |
| Low | $6.82B | $7.99B | $8.83B | $9.91B | $11.34B |
| High | $7.35B | $9.05B | $10.34B | $11.73B | $13.42B |
| Net Income Avg | $7.13B | $8.60B | $9.71B | $11.35B | $13.39B |
| Low | $6.73B | $7.81B | $9.04B | $9.99B | $11.79B |
| High | $7.45B | $10.00B | $11.55B | $12.45B | $14.69B |
| EPS Avg | $5.48 | $6.66 | $7.64 | $8.60 | $10.15 |
| Low | $5.10 | $5.92 | $6.85 | $7.57 | $8.93 |
| High | $5.64 | $7.58 | $8.75 | $9.43 | $11.13 |
| Analysts (Rev / EPS) | 18 / 16 | 16 / 14 | 9 / 5 | 4 / 3 | 4 / 4 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.04B | $4.50B | $4.69B | $4.91B | $5.12B | $5.32B | $5.61B | $5.82B |
| Low | $4.01B | $4.27B | $4.57B | $4.78B | $4.99B | $5.18B | $5.46B | $5.67B |
| High | $4.11B | $4.57B | $4.81B | $5.04B | $5.26B | $5.46B | $5.76B | $5.98B |
| EBITDA Avg | $1.72B | $1.91B | $1.99B | $2.09B | $2.18B | $2.26B | $2.38B | $2.48B |
| Low | $1.70B | $1.81B | $1.94B | $2.03B | $2.12B | $2.20B | $2.32B | $2.41B |
| High | $1.75B | $1.94B | $2.05B | $2.14B | $2.24B | $2.32B | $2.45B | $2.54B |
| EBIT Avg | $1.59B | $1.77B | $1.84B | $1.93B | $2.01B | $2.09B | $2.20B | $2.29B |
| Low | $1.58B | $1.68B | $1.80B | $1.88B | $1.96B | $2.04B | $2.15B | $2.23B |
| High | $1.62B | $1.80B | $1.89B | $1.98B | $2.07B | $2.15B | $2.26B | $2.35B |
| Net Income Avg | $1.56B | $1.81B | $1.91B | $2.02B | $2.11B | $2.20B | $2.33B | $2.44B |
| Low | $1.55B | $1.68B | $1.84B | $1.95B | $2.04B | $2.13B | $2.26B | $2.35B |
| High | $1.61B | $1.86B | $1.97B | $2.09B | $2.19B | $2.28B | $2.41B | $2.52B |
| EPS Avg | $1.18 | $1.37 | $1.44 | $1.53 | $1.60 | $1.67 | $1.77 | $1.85 |
| Low | $1.17 | $1.27 | $1.40 | $1.48 | $1.55 | $1.62 | $1.71 | $1.78 |
| High | $1.22 | $1.41 | $1.50 | $1.58 | $1.66 | $1.73 | $1.83 | $1.91 |
| Analysts (Rev / EPS) | 13 / 14 | 13 / 14 | 6 / 8 | 6 / 6 | 6 / 6 | 6 / 12 | 5 / 13 | 5 / 7 |